GF
PTLA

Gerry Farber’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Gerry Farber’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-40,000
Closed -$1.03M – 84
2013
Q4 		$1.03M Buy
+40,000
New +$972K 1.02% 42

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Gerry Farber's PTLA Position: Q1 2014 in Review

Gerry Farber sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2014, closing a stake of 40,000 shares — an estimated $1.03M sold.

Gerry Farber first reported a position in PTLA in Q4 2013 and held it in 1 quarter. The position peaked at $1.03M in Q4 2013. 102 funds tracked by Wall St. Rank hold PTLA as of Q1 2014.

  • Gerry Farber reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2014 after selling out during the quarter.
  • Gerry Farber sold 40,000 Portola Pharmaceuticals, Inc. shares in Q1 2014, an estimated $1.03M.
  • Gerry Farber first reported a position in Portola Pharmaceuticals, Inc. in Q4 2013 and held it in 1 quarter.
  • Gerry Farber's Portola Pharmaceuticals, Inc. position peaked at $1.03M in Q4 2013.
  • 102 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2014.

Based on Gerry Farber's 13F filing for Q1 2014, filed 16 Apr 2014.